Table 1.
Surface epitope phenotype of bone marrow-, tonsil-, muscle-, and dental pulp-derived mesenchymal progenitor cells*
BM-MPCs | T-MPCs | M-MPCs | DP-MPCs | |
---|---|---|---|---|
CD14 | - | - | - | - |
CD34 | - | - | - | - |
CD45 | - | - | - | - |
CD73 | + | + | + | + |
CD90 | + | + | + | + |
CD105 | + | + | + | + |
*Surface epitopes or CD markers identified on the basis of immuoreactivity analyzed by fluorescence-activated cell sorting (FACS). FACS analysis showed that more than 95% of these cells were negative (-) for the expression of CD14, CD34, and CD45, and were positive (+) for CD73, CD90 and, CD105. Controls consisted of fluorescence observed with isotypic controls. BM, bone marrow; DP, dental pulp; M, muscle; MPC, mesenchymal progenitor cell; T, tonsil.